Subramanian B - Search Results

1

Sponge-derived fijianolide polyketide class: further evaluation of their structural and cytotoxicity properties.

Johnson TA, Tenney K, Cichewicz RH, Morinaka BI, White KN, Amagata T, Subramanian B, Media J, Mooberry SL, Valeriote FA, Crews P. Johnson TA, et al. Among authors: subramanian b. J Med Chem. 2007 Aug 9;50(16):3795-803. doi: 10.1021/jm070410z. Epub 2007 Jul 10. J Med Chem. 2007. PMID: 17622130 Free PMC article.

2

Inhibition of macromolecular synthesis by cryptophycin-52.

Subramanian B, Nakeff A, Media JE, Wiegand RA, Valeriote FA. Subramanian B, et al. Anticancer Drugs. 2002 Nov;13(10):1061-8. doi: 10.1097/00001813-200211000-00010. Anticancer Drugs. 2002. PMID: 12439340

3

Cellular drug action profile paradigm applied to XK469.

Subramanian B, Nakeff A, Media J, Wentland M, Valeriote F. Subramanian B, et al. J Exp Ther Oncol. 2002 Sep-Oct;2(5):253-63. doi: 10.1046/j.1359-4117.2002.01040.x. J Exp Ther Oncol. 2002. PMID: 12416029

4

A new paradigm for the development of anticancer agents from natural products.

Subramanian B, Nakeff A, Tenney K, Crews P, Gunatilaka L, Valeriote F. Subramanian B, et al. J Exp Ther Oncol. 2006;5(3):195-204. J Exp Ther Oncol. 2006. PMID: 16528970 Free PMC article. Review.

5

A comparison of drug-treated and untreated HCT-116 human colon adenocarcinoma cells using a 2-D liquid separation mapping method based upon chromatofocusing PI fractionation.

Yan F, Subramanian B, Nakeff A, Barder TJ, Parus SJ, Lubman DM. Yan F, et al. Among authors: subramanian b. Anal Chem. 2003 May 15;75(10):2299-308. doi: 10.1021/ac020678s. Anal Chem. 2003. PMID: 12918970

6

Painting with a molecular brush: genomic/proteomic interfacing to define the drug action profile of novel solid-tumor selective anticancer agents.

Nakeff A, Sahay N, Pisano M, Subramanian B. Nakeff A, et al. Among authors: subramanian b. Cytometry. 2002 Jan 1;47(1):72-9. Cytometry. 2002. PMID: 11774356

7

Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitination.

Lin H, Liu XY, Subramanian B, Nakeff A, Valeriote F, Chen BD. Lin H, et al. Among authors: subramanian b. Int J Cancer. 2002 Jan 1;97(1):121-8. doi: 10.1002/ijc.1570. Int J Cancer. 2002. PMID: 11774253

8

XK469, a novel antitumor agent, inhibits signaling by the MEK/MAPK signaling pathway.

Lin H, Subramanian B, Nakeff A, Chen BD. Lin H, et al. Among authors: subramanian b. Cancer Chemother Pharmacol. 2002 Apr;49(4):281-6. doi: 10.1007/s00280-002-0425-7. Epub 2002 Jan 24. Cancer Chemother Pharmacol. 2002. PMID: 11914906

9

Formulating Single Phasic Silicorhenanite (α- and β-Na₂Ca₄(PO₄)₂SiO₄) Bioactive Glass Materials Competing with Commercial Crystalline Hydroxyapatite Bone Mineral for Biomedical Applications.

Sugumaran V, Kamalakkannan A, Krishnamoorthy E, Radha G, Subramanian B. Sugumaran V, et al. Among authors: subramanian b. ACS Biomater Sci Eng. 2025 Jan 22. doi: 10.1021/acsbiomaterials.4c01219. Online ahead of print. ACS Biomater Sci Eng. 2025. PMID: 39844531

10

Cardiovascular wellness in low-resource settings: A mobile app-based risk prediction study among fuel filling station employees in Puducherry district.

Ramadass D, Vasudevan J, Dsouza MJ, Subramanian B. Ramadass D, et al. Among authors: subramanian b. J Family Med Prim Care. 2024 Dec;13(12):5714-5719. doi: 10.4103/jfmpc.jfmpc_638_24. Epub 2024 Dec 9. J Family Med Prim Care. 2024. PMID: 39790758 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters